Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,441,000 | 8,710,000 | 12,736,000 | 10,098,000 | 13,915,000 |
| Marketable Securities | 486,000 | 270,000 | 664,000 | 1,054,000 | 900,000 |
| Receivables | 10,629,000 | 11,040,000 | 10,746,000 | 9,787,000 | 9,953,000 |
| Inventories | 9,431,000 | 9,666,000 | 8,960,000 | 8,715,000 | 8,352,000 |
| Other current assets | 13,706,000 | 216,000 | 291,000 | 384,000 | 141,000 |
| TOTAL | $42,588,000 | $30,670,000 | $34,111,000 | $30,653,000 | $33,786,000 |
| Non-Current Assets | |||||
| PPE Net | 11,601,000 | 11,814,000 | 11,684,000 | 11,976,000 | 10,563,000 |
| Investments And Advances | 3,259,000 | 2,666,000 | 2,765,000 | 2,422,000 | 2,105,000 |
| Intangibles | 66,013,000 | 73,723,000 | 71,532,000 | 69,463,000 | 62,785,000 |
| Other Non-Current Assets | 9,337,000 | 7,591,000 | 6,630,000 | 5,728,000 | 5,290,000 |
| TOTAL | $90,210,000 | $95,794,000 | $92,611,000 | $89,589,000 | $80,743,000 |
| Total Assets | $132,798,000 | $126,464,000 | $126,722,000 | $120,242,000 | $114,529,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,209,000 | 2,045,000 | 4,174,000 | 3,183,000 | 2,767,000 |
| Accounts payable and accrued liabilities | 7,551,000 | 7,328,000 | 6,813,000 | 6,180,000 | 5,295,000 |
| Other current liabilities | 12,547,000 | 9,938,000 | 8,108,000 | 7,328,000 | 6,643,000 |
| TOTAL | $29,162,000 | $24,207,000 | $23,974,000 | $21,295,000 | $19,280,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,791,000 | 14,347,000 | 14,857,000 | 17,123,000 | 19,745,000 |
| Deferred Revenues | 0 | 0 | 264,000 | 319,000 | N/A |
| Other Non-Current Liabilities | 9,827,000 | 9,632,000 | 8,626,000 | 8,987,000 | 9,510,000 |
| TOTAL | $25,779,000 | $27,904,000 | $27,596,000 | $29,916,000 | $32,102,000 |
| Total Liabilities | $54,941,000 | $52,111,000 | $51,570,000 | $51,211,000 | $51,382,000 |
| Shareholders' Equity | |||||
| Common Shares | 2,526,000 | 2,530,000 | 2,522,000 | 2,527,000 | 2,518,000 |
| Other shareholders' equity | 75,821,000 | 72,381,000 | 72,843,000 | 66,561,000 | 60,826,000 |
| TOTAL | $77,507,000 | $74,040,000 | $74,784,000 | $68,681,000 | $63,001,000 |
| Total Liabilities And Equity | $132,448,000 | $126,151,000 | $126,354,000 | $119,892,000 | $114,383,000 |